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Abstract:
 
Onset and development of puberty is regulated by the neuroendocrine system. Population-based studies world-
wide have observed secular trends towards earlier puberty development. These changes are apparently caused by environ-
mental factors such as improved socio-economic status, improved health care and nutrition. However, they may also partly
result from endocrine-disrupting chemicals in the environment. Epidemiological studies have investigated the relationship
between pubertal development and exposure to endocrine-disrupting chemicals (polychlorinated biphenyls, polybromi-
nated biphenyls, 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane, phthalate esters, furans and the pesticide endosulfan).
Associations with both perinatal and postnatal exposure have been reported. Studies in experimental animals support some
of these findings and point to differential endocrine regulatory mechanisms linked to pubertal development acting in the
perinatal and the pre-pubertal period. Pubertal development is naturally associated with growth and body composition.
There is increasing evidence for a link between prenatal development and pubertal onset. In girls born small for gestational
age (SGA), pubertal onset and age at menarche often are advanced, especially if  there has been an extensive catch-up
growth during the first months of  life. 
 
In utero
 
 growth retardation may have multiple causes including exposure to
xenobiotic substances as was suggested for some endocrine-disrupting chemicals. An abnormal perinatal environment of
children born SGA may alter the endocrine status and the sensitivity of the receptors for endocrine and metabolic signalling that
may have effects on maturation of brain and gonads. However, the causal pathways and the molecular mechanisms that
may link the pubertal growth pattern of children born SGA, pubertal development and endocrine-disrupting chemicals
 
need further study.
 
Puberty is characterized by rapid physiological changes
such as growth spurt and maturation of the gonads and the
brain. It entails the individual’s transition period from a
non-reproductive to a reproductive state. Moreover, it is an
acknowledged period of emotional stress and vulnerability
to socio-environmental factors [1].
During the past decades, secular trends of earlier age at
onset of puberty have been reported [2]. Not only may this
increase the social burden due to a higher risk of pregnancies
at early ages, changes in the timing of pubertal development
may influence the risk for substance abuse, antisocial behav-
iour, eating disorders and emotional stress. Early sexual
maturation in adolescents has been associated with a higher
prevalence of alcohol and tobacco use in late adolescence
[1]. This vulnerable period of transition into adulthood is
fine tuned by endocrine-regulatory mechanisms [3].
Endocrine-disrupting chemicals have been implicated
in numerous physiological processes affecting normal
reproductive health in human beings and animals [4].
Monitoring changes in pubertal onset and development
may function as early warning signs for reproductive capacity,
both individually and at the population level. Therefore, this
 
MiniReview
 
 will focus on environmental chemicals and what
is known about their impact on puberty development in
relation to critical windows of exposure.
 
Secular trends in puberty onset and development
 
The physiological processes that regulate onset of puberty
and transit through adolescence are not yet fully under-
stood. Next to a genetic component, environmental factors
are influencing timing of puberty onset [2]. While there
seems to be a 4–5-year variation in ‘normal’ starting times
for puberty among healthy children, the onset time varies
between different ethnic groups. For example, puberty onset
may occur between the ages of 8 and 14 in Caucasian girls,
and may begin as early as 7 years of age in African-American
girls. The average age of girls of the Kikuyu of Kenya to
reach puberty onset was 13 years and the average age at
menarche (first ovulation) was 15.9 years, which is much
later than in the USA. African-American and Mexican-
Americans girls are more likely than white girls to have
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‘early menarche’, that is, menarche before 11 years. Asians
are more likely than whites to mature later than 14 years [5].
The improvement of the nutritional and health status
between mid-nineteenth century and the mid-twentieth century
has been associated with an overall decrease in menarcheal
age of  an average 3 years in USA and in some countries
of Western Europe [2]. This trend of decreasing age at
menarche seems to have halted in most European popula-
tions although there are some reports describing further
decreases in the US population [2]. The importance of the
nutritional status has been demonstrated also in children
migrating from developing countries. Danish studies showed
that adopted children from developing countries have a
15–20-time higher risk of developing precocious puberty
compared to Danish-born children [6]. Indian girls adopted
by Swedish families had lower median menarcheal age than
Swedish girls [7]. The nutritional status of these children
changes upon arrival in the host country, which is followed
by a catch-up in height and weight and precedes early sexual
maturation. Earlier pubertal development was more pro-
nounced in girls than in boys and the likelihood depended
also on the age of adoption: precocious menarche (<10 years)
being more common in Indian girls who arrived in Sweden
between 3 and 6 years than in those who arrived before 2
years of age [7]. A relationship between pre-pubertal body
mass index and the timing of puberty has been observed in
retrospective studies in Denmark and in prospective studies
in the USA [6,8]. However, whether the association is
causative is not clear.
 
Markers for pubertal development
 
Puberty is a multifaceted process that may be monitored by
different markers. External signs such as the development of
breasts in girls, the increase in testicular volume in boys and
pubic hair growth are staged in adolescents according to
criteria defined in the pioneering work by Marshall and
Tanner [9,10]. In girls, breast development, pubic hair growth,
age at menarche and regular menstrual cycles are used as
markers for pubertal development. In boys, the increase in
testicular volume, pubic hair growth, spermaturia, age at
first ejaculation, fundamental voice frequency, growth and
height spurt and bone density are markers of  puberty
development [11]. The information on these markers can be
collected non-invasively by health professionals or by self-
assessment questionnaires [12]. However, interobserver varia-
bility may hamper the comparison of results among studies.
Another complication is that the different physiological
changes may be regulated by different triggers and may be
not directly interconnected. Breast development (‘thelarche’,
the onset of breast development) follows the secretion of
ovarian oestrogen, whereas the development of female pubic
hair (‘adrenarche’ or ‘pubarche’, the onset of pubic hair
development) is caused by androgens from both the adrenal
glands and ovaries. Oestrogen secretion and androgen
secretion are controlled separately; thus, adrenarche and
thelarche can occur in either a coordinated manner (which
is the norm) or independently (which is rarer). Menarche
occurs in response to the gonadotropins follicle-stimulating
hormone (FSH) and luteinizing hormone (LH) that are
released by the pituitary. Although menarche occurs generally
in late puberty, about 2.0–2.5 years after breast budding, it
is a singular event and many studies use menarche as a
proxy for the onset of puberty. In boys, testicular enlargement
and the secretion of testicular androgen (both are called
‘gonadarche’) usually, but not always, precede pubic hair
development [13].
As onset of puberty and pubertal progression is under
hormonal control, monitoring endocrine status may offer
useful biomarkers of puberty. The main hormone involved
in the regulation of puberty onset is gonadotropin-releasing
hormone (GnRH) in the hypothalamus that stimulates
release of both LH and FSH from the pituitary [3]. LH
stimulates the production and release by the gonads of tes-
tosterone (boys) and oestrogens (girls) that can be measured
in early puberty as elevated concentrations in morning urine
samples [14]. The secretion of adrenal androgens starts in the
earliest stages of puberty under control of the hypothalamus–
pituitary–adrenal axis. These hormones cause pubic and
axillary hair growth and sensitize the androgen receptors of
the hypothalamus pituitary. Inhibins are peptides of gonadal
origin that suppress FSH production. Inhibin B expression is
high in infant boys but declines in concert with the increase
in gonadotropins. In boys, serum inhibin B levels are markers
of the maturation state of the Sertoli cells, they increase
between Tanner stages 1 and 2, but then plateau [11].
Pre-pubertal changes in weight and height have been
associated with puberty development, and thus it has been
suggested that markers for energy balance and metabolic
status may be early biomarkers for puberty development.
More recently, leptin has been suggested to be the metabolic
messenger between the fat cell and the hypothalamus that
stimulates the onset of puberty [15]. Furthermore, insulin
levels may stimulate hypothalamic neuronal cells to express
and secrete GnRH [15].
The prevalence of precocious puberty has also been used
as a marker for assessing pubertal development [16]. Preco-
cious puberty has been defined in Europe as less than 8
years for the B2 Tanner stage in girls and less than 9 years
for the G2 Tanner stage in boys. These age limits are below
the first percentiles of  the Gaussian distribution in the
normal population. Precocious puberty is more frequent in
girls than in boys. In most cases, precocious puberty is related
to early hypothalamic pituitary maturation that is induced
by gonadotropin and associated with increased LH secretion.
In one-third to one-fifth of  the cases, sexual precocity is
related to increased secretion of  adrenal or gonadal sex
steroids or may be related to enhanced exposure to exoge-
nous compounds [16]. In addition, delayed puberty may be
a marker for abnormal puberty development. Delayed puberty
is diagnosed when there is no breast development by 13.4 years
of age in a girl and no testicular enlargement by 14 years in a
boy [17]. Other markers that have been used are an increased
delay between age at menarche and regular cycling.
 170
 
GREET SCHOETERS 
 
ET AL
 
.
 
MiniReview
 
© 2008 The Authors
Journal compilation
 
 © 2008 Nordic Pharmacological Society. 
 
Basic & Clinical Pharmacology & Toxicology
 
, 
 
102
 
, 168–175
 
Links with environmental pollution
 
Many reports have suggested a role of exogenous endocrine-
disrupting chemicals in timing and development of puberty.
Few epidemiological studies have addressed this hypothesis.
These studies have been reviewed [18,19].
In many of these studies, timing of pubertal stages and
menarche were self-reported. The size of the study popula-
tions varies also largely. Changes of pubertal development
have been associated to perinatal dose (table 1) or to pre-
pubertal dose (table 2). Doses are extrapolated from maternal
serum concentrations or from serum concentrations at the
time of accidental contamination.
In Belgium, high levels of  1,1-dichloro-2,2-bis(p-
chlorophenyl)ethylene (p,p
 
′
 
-DDE) were found in 26
immigrant girls (adopted and non-adopted) with precocious
puberty [20]. The insecticide 1,1,1-trichloro-2,2-bis(p-
chlorophenyl)ethane (DDT) can behave as an oestrogen
agonist and its major metabolite p,p
 
′
 
-DDE has anti-androgen
potency as shown by 
 
in vitro
 
 and animal studies [21,22].
In the so-called Michigan angler cohort, 
 
in utero
 
 exposure
to high levels of DDE was associated with advanced age at
menarche as measured in 151 daughters from fish-eating
mothers compared to controls, polychlorinated biphenyls
(PCB) having no effect on age at menarche [23]. The daughter’s
age at menarche and possible confounders were acquired by
telephone interviews [23]. This finding was not confirmed in
the North Carolina cohort in which self-reported age at
menarche or pubertal stage in 316 girls and 278 boys was
not associated with DDE [24].
Polychlorinated biphenyls have been described to display
oestrogenic, anti-oestrogenic and anti-androgenic activities
[25]. There are already several epidemiological studies that
have assessed exposure to PCBs in relation to the timing of
puberty. In a Belgian study comparing children (120 girls
and 80 boys) from rural and urban areas, PCB congeners
138, 153 and 180 were measured in serum, and the pubertal
stage was assessed by physicians [26,27]. No association of
PCB levels to pubertal development in girls was observed,
whereas in boys, a significant delay of  puberty was found
in urban areas and in association with high PCB levels. In a
recent study in Flanders including 1600 adolescents
enhanced genital development and pubic hair growth has
been observed in boys in relation to levels of p,p
 
′
 
-DDE and
PCBs in serum (unpublished results). In the North Carolina
Infant Feeding Study, no association of  PCB exposure
to the self-reported timing of puberty (including age at
menarche) among 316 girls and 278 boys was found,
although there was a non-significant tendency to early
maturation in the girls in the highest prenatal exposure
group [24]. Two studies from the Great Lake area, Michigan
in USA, found no correlation of PCB exposure to self-
reported timing of puberty in 327 girls [28] or 151 girls [23].
Similar results were found in a boy cohort (196 boys) from
Faroe Islands, that is, no association of PCB exposure to the
timing of  puberty [29]. In Yucheng, 55 boys who were
accidentally exposed to high PCB and polychlorinated
dibenzofuran (PCDF) levels were reported to have shorter
penile length than the control boys at the same age, suggest-
ing pubertal delay [30]. In summary, epidemiological studies
have not revealed any association of PCB exposure with the
timing of puberty in girls, whereas in boys there are two
studies suggesting a link to delayed puberty and two studies
showing no effect.
Table 1.
Epidemiological studies investigating the relationship between perinatal exposure and pubertal development.
Compound Study area
Study 
population Methods Main findings Reference
DDE Michigan angler cohort of 
fish eating mothers with 
serum DDE levels at time 
of pregnancy up to 25 µg/l
151 girls Retrospective study Reduced age at menarche by 1 
year associated with an 
increase in in utero DDE 
exposure of 15 µg/l
[23]
PCBs Telephone interviews
In utero exposure calculated from 
maternal serum levels
DDE North Carolina cohort with 
DDE concentrations up to 
4 µg/g fat
316 girls Prospective study No association with pubertal 
stages
[24]
PCBs 278 boys Mail questionnaires
Concentrations in mothersmilk 
and maternal serum
PBBs Michigan food chain 
contamination 
327 girls Prospective study Earlier age at menarche and 
earlier pubic hair stage in 
breastfed girls with in utero 
PBB exposure above 7 ng/g 
serum
[28]
Physical examination
In utero exposure extrapolated 
from maternal serum levels at 
the time of the accident
PCBs Faroese birth cohort 196 boys Prospective study No effect on pubertal stages or 
testicular volume
[29]
Clinical and physical examination
Concentrations in cord blood 
PCBs Yucheng 55 boys Prospective study Pubertal delay [30]
PCDFs Clinical and physical examination
Maternal serum levels
DDE, 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene; PBB, polybrominated biphenyl; PCB, polychlorinated biphenyl; PCDF, polychlorinated
dibenzofuran.
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Dioxins act through the aryl hydrocarbon receptor (AhR)
and have anti-oestrogenic effects 
 
in vitro 
 
[31]. Oestrogenic
effects, however, have been reported as well through inter-
action of  the dioxin–AhR–nuclear translocator complex
with oestrogen receptors [32]. A retrospective study of girls
exposed to dioxins in Seveso in 1976 found no association
with age at menarche [33]. In a Belgian study of children
from rural and two urban areas, dioxin exposure was
estimated with the chemically activated luciferase expression
(CALUX) assay that measures the total dioxin-like activity
in serum. There was no correlation of the activity with the
age at menarche or pubic hair development, but high
exposure was associated with a delay in breast development.
In boys, there was no correlation of dioxin-like activity with
pubertal development [26,27].
More than 4000 individuals were accidentally exposed to
polybrominated biphenyls (PBBs) through the food chain in
Michigan in 1973. In a follow-up study of 327 girls, an earlier
age at menarche and earlier pubic hair development were
reported in girls that had been exposed to high PBB levels
 
in utero
 
 and by breastfeeding than those who were less
exposed and received no breastfeeding. No differences were
found in breast development [28].
High lead levels in blood were associated with a delayed
age at menarche and delayed pubic hair development in two
studies that were based on the National Health and Nutrition
Examination Survey in the USA (NHANES III) [34,35].
Breast development was also found to be delayed in the
study including 2186 girls [35].
Some newer less-persistent compounds also have hormonal
activity. Only a few studies have addressed a possible link
between exposure to these compounds and puberty development.
Endosulfan exhibits oestrogenic activity 
 
in vitro
 
 and
reduces plasma FSH, LH and testosterone in rats [36,37].
Pubertal delay was associated to a high endosulfan exposure
in a recent Indian study where 117 boys from a highly con-
taminated area were compared to 90 matched control boys
from an uncontaminated area [38].
A Puerto Rican epidemy of thelarche has prompted studies
on several putative endocrine disrupters, including phthalates
Table 2.
Epidemiological studies investigating the relationship between pubertal exposure and pubertal development.
Compound Study area Study population Methods Main findings Reference
DDE Precocious puberty 
patients (Belgium)
26 immigrant girls and 
15 native Belgian girls
Patients study High levels of plasma DDE 
in immigrant girls (1.04–
1.2 µg/l) compared to 
Belgian native controls 
(<0.01 ng/ml)
[20]
Interviews/physical 
examination
Serum measurements
PCBs One rural and two 
urban villages in 
Belgium
80 boys and 120 girls (17–
18 years old)
Cross sectional study Retarded pubertal 
development associated 
with higher PCB exposure 
in boys
Retarded breast 
development associated 
with higher dioxin levels 
in girls
[27]
Dioxin measured 
by CALUX
Physical examination
Mean serum PCB levels: 
190 (girls) and 360 (boys) 
pmol/g fat
Pubertal serum levels
Mean serum CALUX 
levels: 29 (girls) and 35 
(boys) pg Teq/g fat
Dioxins Seweso 282 girls exposed 
pre-pubertal
Archived serum 
levels from time of 
the accident and 
extrapolated to age 
at menarche
No effect on age at 
menarche
[33]
Lead NHANESIII cross 
sectional study
2186 girls Cross sectional study Delayed pubertal 
development (breast and 
pubic hair stage), delayed 
age at menarche associated 
with bloodlead >3 µg/dL
[34]
Physical examination
Blood lead levels
Lead NHANESIII cross 
sectional study
1235 girls (0.7–21.7 µg/dl 
blood lead)
Cross sectional study Delayed attainment of 
menarche and pubic hair 
growth
[35]
Physical examination
Blood lead levels
Endosulfan Indian village with 
high levels of 
endosulfan used as 
pesticide
117 boys with serum 
endosulfan levels of 
7.6 ng/g/90 controls with 
serum levels of 1.4 ng/g
Cross sectional study Delayed sexual maturation 
(tanner stages)
[36]
Physical examination
Serum levels
Phthalates Puerto Rico 41 patients with premature 
breast development/35 
controls
Case control study Higher levels of DEHP 
(average of 450 ng/ml) and 
MEHP (average of 3 ng/ml) 
in serum of patients (p.p.b. 
range)
[39]
Physical examination
Serum analysis
CALUX, chemically activated luciferase expression; DDE, 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene; DEHP, di(2-ethylhexyl)phthalate;
MEHP, mono-(2-ethylhexyl)phthalate; PCB, polychlorinated biphenyl.
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[39]. Furthermore, in a case-control study of 41 girls with
thelarche and 35 controls, two-thirds of the cases had meas-
urable phthalate levels in serum, whereas only 14% of the
controls had detectable phthalates. However, the phthalate
profile in serum raised a concern about possible technical
errors (or contamination), because diethylhexyl phthalate
concentrations were high as compared to other phthalates
[40].
Despite the long-time lapse between birth and puberty
onset, three out of six studies reported in table 1 have shown
an influence of perinatal exposure on timing of pubertal
development. In addition, pubertal exposure has been asso-
ciated with changes in pubertal development. The existing
data do not allow a clear identification of the sensitive time
window(s) because the persistent compounds that are studied
are already present at the beginning of life and exposure
continues throughout life. Follow-up studies including
serial serum measurements at time of birth and at pubertal
development would be helpful. Another limitation inherent
to the epidemiological studies is that human beings are not
exposed exclusively to the chemical being investigated, but
instead to a mixture of chemicals, some of them acting through
common pathways. In addition, no single compound can
act as a surrogate or marker for the others, because the
contaminant profile varies among individuals.
Compared to girls, the number of studies studying the
effect of endocrine disrupters on pubertal development in
boys is much more limited. Research in boys is more focused
on semen quality, which is much more closely related to
fertility.
 
Animal experiments and mode of action
 
Animal models have been developed to test the potency of
single compounds to evoke changes in pubertal develop-
ment. Vaginal opening in the female rodent is the initial
sign of the oestrogenic rise that accompanies the onset of
puberty and first ovulation, also disturbances of oestrus
cycle and changes in uterus weight mark pubertal events in
rodents [41]. Exposure with endocrine-disrupting chemicals
may start 
 
in utero
 
 or after birth, allowing to distinguish the
relative importance of prenatal versus postnatal exposure.
Advancement in the age at vaginal opening was reported
after prenatal exposure to oestradiol, diethylstilboestrol,
coumestrol, bisphenol A, octylphenol, nonylphenol, butyl
benzyl phthalate, dibutyl phthalate and after exposure with
genistein shortly after birth [19]. For some endocrine-
disrupting chemicals such as lindane and genistein exposure
during gestation accounted for some delay [42]. Irregular
oestrus cycles and increases in uterine weight, the latter
which is known to be a marker of oestrogenicity, were also
commonly observed after exposure to endocrine-disrupting
chemicals [19].
In rodents, central programming of sexual maturation
takes place between the last week before birth and the first
postnatal week [43]. At early exposure times during foetal
life and/or the suckling period, an effect on priming of the
hypothalamus pituitary axis (HP) was suggested in some rat
studies as shown by changes in serum levels of the pituitary
hormones FSH and LH. As an example, after exposure to
diethylstilboestrol, FSH and LH levels were reduced [44].
Laboratory rodents exposed perinatally to bisphenol A had
lower plasma LH concentrations than control animals after
long-term ovariectomy [45]. After 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) exposure of immature female rats, both
inhibitory and stimulatory responses were observed on the
HP axis, as shown by decreases and increases of peak serum
levels of FSH and LH [46]. These interferences of endocrine-
disrupting chemicals with the HP axis may be due to stimu-
lation of hypothalamic neuronal or pituitary gland cells.
Endocrine-disrupting chemicals may exert both indirect
and direct effects on hypothalamic GnRH secreting neurons
as oestrogen receptors are present in neurons that project to
GnRH neurons, and have been localized within GnRH
neurons themselves [47] (fig. 1). 
 
In vivo
 
 and 
 
in vitro
 
 studies
have shown oestrogen receptors and androgen receptors in
the immature brain. Preliminary observations [19] indicate
that o,p
 
′
 
-dichlorodiphenyltrichloroethane could have stimu-
latory effects on GnRH secretion with involvement of
oestrogen receptors and the glutamate receptor as well as
the orphan dioxin receptor [32]. Two PCB mixtures, Aroclor
1221 (A1221) and A1254, have been shown to influence
GnRH transcript and peptide levels after exposure of the
hypothalamic neuronal GT1–7 cells 
 
in vitro 
 
[48].
Fig. 1. Schematic illustration of perinatal and postnatal targets for
endocrine-disrupting chemicals (EDC) in relation to possible health
outcomes.
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Alternatively, some compounds such as DDT are known to
interfere with brain aromatase, which converts testosterone
into oestrogen in the immature brain [49]. The conversion of
testosterone to oestradiol plays an important role in the
sexual differentiation of the rodent brain [50]. Endocrine-
disrupting chemicals may also affect circulating levels of
steroids by interfering with steroid production by gonads
or with steroid metabolism or with their transporters or
their receptors. In immature rats, increased levels of oestrogen
activity may suppress GnRH and the pituitary gonado-
trophins by a negative feedback control mechanism [51]. In
the mature female, a positive (stimulating) feedback may
lead to an increase in the preovulatory GnRH and gonado-
trophin (FSH and LH) release [3,52] and may enhance
puberty onset (fig. 1). The animal data tend to substantiate the
effects of endocrine-disrupting chemicals on the hypothalamo–
pituitary–gonadal axis that influence sexual maturation and
reproduction in female rodents. Direct and indirect effects
through feedback mechanisms on hypothalamic and pituitary
secreting functions are observed. Furthermore, direct effects
on gonadal and adrenal function may contribute to changes
in puberty development (fig. 1). The impact on puberty
onset may be different according to the timing of exposure.
 
Prenatal imprinting
 
As mentioned above, animal studies have suggested that
exposure to endocrine-disrupting chemicals 
 
in utero
 
 and in
early postnatal stage may influence puberty onset and develop-
ment. In addition, in human beings there is growing evidence
to suggest that the prenatal and early postnatal period may
represent an early window of susceptibility to long-term
‘programming’ of various reproductive outcomes including
puberty development. In girls bornSGA, pubertal onset and
age at menarche often are advanced, especially if  there has
been an extensive catch-up growth during the first months
of life [53]. In boys born SGA, pubertal timing is reported
normal but adult height and testicular volume may be
below target [54]. In the UK, MRC 1946 birth cohort, earlier
puberty was related to smaller size at birth and rapid growth
between 0 and 2 years. Rapid early weight-gain led to taller
childhood stature and higher insulin-like growth factor I
(IGF-I) levels, possibly through early induction of growth
hormone (GH) receptor numbers, and such children were also
at risk of childhood obesity [55]. In the Avon Longitudinal
Study of Parents and Children, rapid infancy weight-gain
was associated with increased risk of obesity at 5 and 8
years, with evidence of insulin resistance, exaggerated adren-
arche and reduced levels of sex hormone binding globulin
(SHBG) [55]. The role of fat-derived signals, such as leptin,
or body size-linked signals, such as IGF-I, or other factors
related to energy availability, such as glucose, for timing of
puberty and regulation of reproduction is not clear. Data
from feed-restricted rats support the notion that leptin could
serve as a link between nutritional status and the reproductive
axis, and in this way participate in the timing of puberty.
The brain might initiate puberty in response to adequate
leptin signalling from the periphery [56]. 
 
In vitro
 
 studies
have shown that both insulin and leptin that are metabolic
factors signalling the nutritional status can trigger hypo-
thalamic neuronal cells and stimulate the expression and
secretion of GnRH [57]. Leptin controls also the expression of
kisspeptins, which are potent stimulators of hypothalamic
GnRH secretion [58]. Enhanced expression of KiSS-1 and
their G protein-coupled receptor GPR54 genes, as well as
increased GPR54 signalling, are detected at the hypothala-
mus during pubertal development. Activation of GPR54 by
administration of kisspeptin is sufficient to induce precocious
activation of  the gonadotropic axis in immature rodents
and monkeys. Moreover, kisspeptin-expressing neurons are
direct targets for the negative and positive feedback actions
of sex steroids. Hypothalamic KiSS-1 seems to function as
an integrator for peripheral inputs, including gonadal steroids
and nutritional signals, controlling gonadotropin-releasing
hormone and gonadotropin secretion [59]. Another candi-
date messenger between nutritional status/energy balance
and the hypothalamus is ghrelin [57], which is also capable
of  stimulation of  pulsatile GnRH secretion from pre-
pubertal rat hypothalamic explants. It is now accepted that
different metabolic signals, including glucose, insulin and
leptin, are capable of modulating reproductive axis activity
under specific circumstances, but their exact physiological
role remains unknown.
Evidence is also growing that exposure to endocrine-
disrupting chemicals may also lead to intra uterine growth
retardation and hence may relate to late health effects such
as changes in puberty development [60]. In male infants,
higher total 
 
in utero
 
 PCB exposure was associated with
reduced birth weight, smaller head circumference and
reduced weight-for-gestational age. In girls, smaller head
circumference and shorter gestations were observed. Prenatal
PCB levels were further associated with greater growth in
5-year-old girls, but no apparent effect in 5-year-old boys
[61]. Experimental studies have shown a negative effect of
developmental PCB exposure on postnatal growth in pri-
mates [62] and rodents [63]. The pathways by which xeno-
oestrogens induce intra uterine growth retardation are not
fully elucidated. Their interference with steroid and thyroid
regulatory mechanisms may play a role. Also direct inter-
ference of the steroid activity with lipid metabolism or through
induction of liver metabolizing enzymes and pathways may
trigger metabolic signals that may act upon the HP axis. It
is not yet clear whether these changes in prenatal and early
postnatal growth and changes in puberty onset are related
in a causal way or are independent targets that are triggered
by the same factors.
 
Conclusion
 
Puberty marks a transition between childhood and the adult
reproductive stage. It is a vulnerable stage of life and deregu-
lation has been linked to increased health and psychosocial
problems. Puberty development is a multifaceted process
that is under control of different hormonal regulatory
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mechanisms. The exact triggers are not yet elucidated.
Epidemiological and animal experiments provide evidence
for a role of pre-pubertal changes in hormonal control
mechanisms but also for early perinatal programming
windows. Evidence is accumulating that exogenous hormone
disruptors may advance or sometimes delay puberty.
Associations are found between birth outcome, postnatal
growth and puberty development, but the causal links are
far from understood. Experimental work suggests that
exogenous chemicals interfering with targets related to growth,
lipid metabolism, differentiation and functioning of brain,
gonads and adrenals may play a role. Carefully designed
epidemiological studies using exposure markers to endocrine-
disrupting chemicals around and/or after birth and in the
pre-pubertal stage in combination with markers for
endocrine and metabolic status are needed to disentangle
eventual causal pathways in environmental settings. We should
also be aware that it is not the exposure to an individual
chemical, but the cumulative exposure to multiple xenohor-
mones that will define the final impact. Monitoring changes
in puberty development should be seen as a sentinel for the
impact of environmental changes on developmental and
sexual health.
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